Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching

[1]  Ming Chen,et al.  Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI , 2019, BMC Cancer.

[2]  Ming Chen,et al.  Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching , 2019, Translational oncology.

[3]  J. Galvin,et al.  Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer , 2018, JAMA oncology.

[4]  J. Galvin,et al.  Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial , 2018, JAMA oncology.

[5]  S. Senan,et al.  Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies. , 2018, International journal of radiation oncology, biology, physics.

[6]  S. Jolly,et al.  Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Berry,et al.  A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer , 2017, The Journal of thoracic and cardiovascular surgery.

[8]  B. Solomon,et al.  Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer , 2017, British Journal of Cancer.

[9]  P. Xia,et al.  A Histologic Basis for the Efficacy of SBRT to the lung , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  E. Yorke,et al.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[11]  J. Thariat,et al.  Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy? , 2016, Medicine.

[12]  Abby J. Isaacs,et al.  Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis , 2016, British Medical Journal.

[13]  A. Gajra,et al.  Management of Lung Cancer in the Elderly. , 2016, Clinics in geriatric medicine.

[14]  C. Gross,et al.  Comparative effectiveness of surgery and radiosurgery for stage I non–small cell lung cancer , 2015, Cancer.

[15]  Peter Balter,et al.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. , 2015, The Lancet. Oncology.

[16]  A. Bogers,et al.  Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. , 2015, Lung cancer.

[17]  R. Weichselbaum,et al.  Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. , 2015, International journal of radiation oncology, biology, physics.

[18]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.

[19]  Edith M Marom,et al.  Update in the evaluation of the solitary pulmonary nodule. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  S Senan,et al.  2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Dan Cao,et al.  Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  H. Asamura,et al.  Sublobar resection for early-stage lung cancer. , 2014, Translational lung cancer research.

[23]  S. Broderick,et al.  Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. , 2014, The Journal of thoracic and cardiovascular surgery.

[24]  William Y. Song,et al.  Stereotactic body radiation therapy in octogenarians with stage I lung cancer. , 2014, Clinical lung cancer.

[25]  M. Lodge,et al.  Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  J. Rathmell,et al.  Results of the two incidence screenings in the National Lung Screening Trial. , 2013, The New England journal of medicine.

[27]  Deruo Liu,et al.  Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  John Flickinger,et al.  Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery , 2013, Cancer.

[29]  Pietro Mancosu,et al.  Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC). , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  E. Smit,et al.  Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Jeffrey D Bradley,et al.  Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  S. Senan,et al.  Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. , 2013, Clinical lung cancer.

[33]  Joe Y. Chang,et al.  Clinical Investigation : Thoracic Cancer Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly , 2012 .

[34]  M. Berry,et al.  Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function: A Society of Thoracic Surgeons Database Analysis , 2012, Annals of surgery.

[35]  Laura N. Medford-Davis,et al.  Matched-pair comparison of outcome of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. , 2012 .

[36]  Suresh Senan,et al.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[37]  J. Donington.  Point: are limited resections appropriate in non-small cell lung cancer? Yes. , 2012, Chest.

[38]  Aaron Ward,et al.  Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  J. Sonke,et al.  Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[40]  Hiroki Shirato,et al.  Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? , 2011, International journal of radiation oncology, biology, physics.

[41]  P. Parikh,et al.  Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[42]  S. Senan,et al.  Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  R. Malthaner,et al.  Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. , 2011, Chest.

[44]  S. Senan,et al.  Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer , 2011, Current opinion in oncology.

[45]  K. Togashi,et al.  Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  Umberto Ricardi,et al.  Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.

[47]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[48]  Hong Ye,et al.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  N. Altorki,et al.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. , 2010, The Journal of thoracic and cardiovascular surgery.

[50]  A. Bosch,et al.  Institutional report - Thoracic oncologic Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands , 2010 .

[51]  S. Senan,et al.  Stage I nonsmall cell lung cancer in patients aged ≥75 years , 2010, Cancer.

[52]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[53]  R. Rami-Porta,et al.  ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[54]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[55]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.